ThrombUS: Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis.

 

Deep vein thrombosis (DVT) poses a significant health risk, with potentially life-threatening consequences when left undetected. DVT involves the formation of blood clots in deep veins, primarily in the lower limbs, leading to blood flow obstruction. Shockingly, up to two-thirds of DVT cases exhibit no clinical symptoms, making early diagnosis challenging.
The ThrombUS+ project is focused on developing a novel wearable diagnostic device to aid in the early detection and diagnosis of deep vein thrombosis (DVT). The project integrates cutting-edge technologies, including ultrasound, artificial intelligence, light reflection rheography, plethysmography, serious games, and extended reality, to create a comprehensive and user-friendly monitoring system. ThrombUS+ aims to provide patients and healthcare professionals with real-time insights, enhancing DVT diagnosis and treatment.

 

The primary objectives include:

 

  • Early and Autonomous DVT Detection

 

  • Continuous Monitoring for High DVT Risk Patients

 

  • Integration of AI-Driven Decision Support

 

  • Support for DVT Prevention via Serious Gaming

 

  • Extended Reality for Optimal Device Usage

 

  • Large-Scale Clinical Studies for AI Training

 

ThrombUS+ aims to transform the landscape of DVT management by improving diagnosis, monitoring, and prevention through technological innovation.

 

For more info on ThrombUS+, please visit:
https://thrombus.eu/

In collaborazione con:
1. Athena Research Center (Greece)

2. Kaunas Technical University (Lithuania)

3. VERMON SA (France)

4. Fraunhofer Institute for Photonic Microsystems (Germany)

5. Closed joint-stock company “Telemed” (Lithuania)

6. EchoNous Inc (USA)

7. medis Medizinische Messtechnik GmbH (Germany)

8. ComfTech SLR (Italy)

9. Tampere University (Finland)

10. Lithuanian University of Health Sciences (Lithuania)

11. General Hospital Papageorgiou (Greece)

12. Foundation Casa Sollievo della Sofferenza (Italy)

13. Hospital Simon Veil Eaubonne Montmorency (France)

14. Association of Electrical, Electronics, and Information Technology EV (Germany)

15. Medea s.r.l. (Italy)

16. Phaze Clinical Research & Pharma Consulting SA (Greece)

17. PREDICTBY Research and Consulting SL (Spain)

18. SciGen Technologies SA (Greece)

Details

  • European Commission
  • Impact assessment & maximization
  • Deep Vein Thrombosis Prevention
  • Decision Makers, Users, Social and Healthcare Services, Hospitals, Airlines
  • Social and Healthcare Services and Medical devices